机器人辅助肝癌根治术治疗乙肝相关性肝癌的疗效分析OA

Objective:To analyze the clinical efficacy of robot-assisted radical hepatectomy in the treatment of hepatitis B virus(HBV)-related hepatocellular carcinoma(HCC).Methods:120 patients with HBV-related HCC who underwent radical hepatectomy at Shengjing Hospital of China Medical University from January 2024 to June 2025 were enrolled.They were randomly divided into the control group(n=60,undergoing open radical hepatectomy)and the observation group(n=60,undergoing robot-assisted radical hepatectomy)using a random number table.Surgical indicators,postoperative recovery indicators,pain levels,and perioperative changes in liver function and inflammatory mediators were compared between the two groups.Results:The total operative time was longer in the observation group than that in the control group,while the total portal clamping time,resection margin distance,time to first ambulation,time to first flatus,time to first defecation,and total length of hospital stay were significantly shorter in the observation group(P＜0.05).Intraoperative blood loss was significantly lower in the observation group than that in the control group(P＜0.05).Visual analog scale(VAS)scores at 12 h,24 h,48 h,and 72 h postoperatively were all significantly lower in the observation group than those in the control group(P＜0.05).3 days after surgery,the magnitudes of change in ALT,AST,TBil,IL-6,CRP,ALB,and TNF-α were significantly smaller in the observation group than those in the control group(P＜0.05).Conclusion:Compared with open radical hepatectomy,robot-assisted radical hepatectomy has greater advantages in treating HBV-related HCC.It can enhance overall surgical efficiency,reduce surgical trauma,ensure complete tumor resection,thereby promoting postoperative recovery,reducing liver function impairment and decreasing systemic inflammatory response.